Advertisement

Inpharma Weekly

, Volume 1330, Issue 1, pp 18–18 | Cite as

Alemtuzumab reduces mortality and morbidity following unrelated donor stem cell transplantation

Clinical study
  • 4 Downloads

Keywords

Melphalan Haematological Malignancy Evaluable Patient Fludarabine Alemtuzumab 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2002

Personalised recommendations